small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 35 results

Practice Area

Copyright-Infringement Litigation

Practice Area

Crisis Management

Addressing a crisis in today’s climate requires both swift action and careful consideration of all potential risks. Winston & Strawn is a trusted business adviser to clients facing complex, fast-moving, high-profile crises....Read more

Practice Area

Fund Finance

We advise clients that originate, manage, and invest in broadly syndicated and middle-market corporate loans with their fund formation and capital markets fund-financing activities. Our experience includes structure and formation of CLOs, registered funds, hedge funds, listed funds, private credit funds, managed accounts, synthetic funds, SBICs, and onshore and offshore special purpose investment vehicles. Our experience spans the complete spectrum of services, including warehouse, leverage, and subscription facilities and ongoing portfolio support. Our Capital Markets Practice has extensive experience in debt and equity offerings, spin-offs, split-offs, and carve-outs, as well as securities compliance and corporate governance....Read more

Experience 7 results

Experience

|

November 11, 2024

Court Square Capital Partners in its Definitive Agreement to Sell Advanced Diabetes Supply Group for US$1.1B

A team led by Craig Godshall and Matthew Schlosser represented Court Square Capital Partners, a New York-based leading middle-market private equity company, in its entry into a definitive agreement to sell Advanced Diabetes Supply® Group, a California-based national distributor of Durable Medical Equipment specializing in diabetes supplies, to Cardinal Health for US$1.1B. This sale will allow ADSG to continue to expand its reach and enhance the way it serves its approximately 500,000 patients nationwide with advances in in-home delivery of diabetes products including continuous glucose monitoring devices and other testing supplies....Read more

Experience

|

January 16, 2024

Represented The Honey Pot Company Holdings, LLC, a leading better-for-you feminine care brand, in the sale of a controlling stake in the business to Compass Diversified (NYSE: CODI)

Winston & Strawn represented The Honey Pot Company Holdings, LLC (“The Honey Pot Co.”), a leading better-for-you feminine care brand in connection with the acquisition of a controlling stake in the business by Compass Diversified (NYSE: CODI) ("Compass”). Compass and The Honey Pot entered into a definitive agreement for an enterprise value of $380 million (excluding working capital and certain other adjustments upon closing). The Honey Pot Co. will continue to be led by its current leadership team and existing owners and management will retain a significant minority stake in The Honey Pot Co....Read more

Experience

|

July 1, 2021

Chart Industries's Acquisition of L.A. Turbine

Winston & Strawn LLP represented Chart Industries, Inc. (NYSE: GTLS), a leading independent global manufacturer of highly engineered equipment servicing multiple applications in the energy and industrial gas markets, in its acquisition of L.A. Turbine for US$80M in cash (subject to certain customary adjustments). L.A. Turbine is a global leader in turboexpander design, engineering, manufacturing, assembly, and testing process for new and aftermarket equipment, with significant in-house engineering expertise. Chart now can offer a more comprehensive “one-stop-shop” solution and provide more options for its customers in a variety of applications....Read more
View All Experience

Insights & News 707 results

Press Release

|

April 7, 2026

|

2 Min Read

Winston Expands White Collar & Government Investigations Practice with Partners Anne Murray and Guy Singer

Washington, D.C. & New York – April 7, 2026 – Winston & Strawn LLP announced today that Anne Murray and Guy Singer have joined the firm’s Litigation Department as partners in its Washington, D.C. and New York offices respectively....Read more

Product Liability & Mass Torts Digest

|

April 3, 2026

|

8 Min Read

A Recipe for Exclusion: Why the Baby Food MDL Experts Failed Under Daubert

In a high-stakes decision on expert exclusion authored late last month, the District Court for the Northern District of California granted defendants’ motion to exclude plaintiffs’ general causation expert witnesses in In re Baby Food Products Liability Litigation—a consolidated mass tort of over 100 pending cases regarding the alleged presence of toxic heavy metals in baby food.

Capital Markets & Securities Law Watch

|

March 26, 2026

|

5 Min Read

SEC Clarifies the Application of Federal Securities Laws to Crypto Assets

On March 17, 2026, the Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC) issued a joint interpretation clarifying in large part how the federal securities laws apply to certain crypto assets and related market participants.

View All Insights & News

Other Results 19 results

Site Content

What Is a Design Defect?

In the product liability context, a design defect claim arises when a plaintiff alleges that a product is inherently dangerous due to its design, rendering it unreasonably unsafe for its intended use. This type of claim does not focus on manufacturing errors but instead asserts that the product's fundamental design flaw poses an unreasonable risk of harm to consumers....Read more

Site Content

What Is GIPA?

The Illinois Genetic Information Privacy Act (GIPA), enacted in 1998, prohibits employers and their agents from conditioning employment on genetic data, or from using genetic data in discriminatory ways. The statute also prohibits insurers from seeking genetic information to use in connection with accident or health insurance policies....Read more

Site Content

What Is the Cooling-Off Period for an IPO?

The cooling-off period is the period of time between the public filing of a registration statement with the SEC and the date the registration statement becomes effective. During this period, no sales may take place. Written offers may only be made with a prospectus meeting the requirements of Section 10 of the Securities Act. Certain oral offers including roadshow presentations may occur during this time along with testing the waters (TTW) activities with certain potential investors.  ...Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising